Please use this identifier to cite or link to this item:
Title: Antidiabetic Polypill Improves Central Pathology and Cognitive Impairment in a Mixed Model of Alzheimer's Disease and Type 2 Diabetes.
Authors: Infante-Garcia, Carmen
Ramos-Rodriguez, Juan Jose
Hierro-Bujalance, Carmen
Ortegon, Esperanza
Pickett, Eleanor
Jackson, Rosemary
Hernandez-Pacho, Fernando
Spires-Jones, Tara
Garcia-Alloza, Monica
Keywords: Alzheimer’s disease;Amyloid-beta;Hemorrhage;Inflammation;Polypill;Tau;Type 2 diabetes
metadata.dc.subject.mesh: Alzheimer Disease
Amyloid beta-Peptides
Cerebral Hemorrhage
Cognitive Dysfunction
Diabetes Mellitus, Type 2
Disease Models, Animal
Hypoglycemic Agents
Mice, Transgenic
tau Proteins
Issue Date: 9-Dec-2017
Abstract: Type 2 diabetes (T2D) is an important risk factor to suffer dementia, being Alzheimer's disease (AD) as the most common form. Both AD and T2D are closely related to aging and with a growing elderly population it might be of relevance to explore new therapeutic approaches that may slow or prevent central complications associated with metabolic disorders. Therefore, we propose the use of the antidiabetic polypill (PP), a pharmacological cocktail, commonly used by T2D patients that include metformin, aspirin, simvastatin, and an angiotensin-converting enzyme inhibitor. In order to test the effects of PP at the central level, we have long-term treated a new mixed model of AD-T2D, the APP/PS1xdb/db mouse. We have analyzed AD pathological features and the underlying specific characteristics that relate AD and T2D. As expected, metabolic alterations were ameliorated after PP treatment in diabetic mice, supporting a role for PP in maintaining pancreatic activity. At central level, PP reduced T2D-associated brain atrophy, showing both neuronal and synaptic preservation. Tau and amyloid pathologies were also reduced after PP treatment. Furthermore, we observed a reduction of spontaneous central bleeding and inflammation after PP treatment in diabetic mice. As consequence, learning and memory processes were improved after PP treatment in AD, T2D, and AD-T2D mice. Our data provide the basis to further analyze the role of PP, as an alternative or adjuvant, to slow down or delay the central complications associated with T2D and AD.
metadata.dc.identifier.doi: 10.1007/s12035-017-0825-7
Appears in Collections:Producción 2020

Files in This Item:
There are no files associated with this item.

This item is protected by original copyright

Except where otherwise noted, Items on the Andalusian Health Repository site are licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives License.